Skip to content

Epigenetic Mechanism of Chronic Obstructive Pulmonary Disease Mediated by Repeated Pulmonary Infection in Early Life

Study on Epigenetic Mechanism of Guben Zhike Chinese Medicine on Chronic Obstructive Pulmonary Disease Mediated by Repeated Pulmonary Infection in Early Life

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100763
Enrollment
Unknown
Registered
2025-04-15
Start date
2025-04-21
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Repeated Pulmonary Infection and Chronic Obstructive Pulmonary Disease

Interventions

Children with recurrent pulmonary infection group:None

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 1-18 years, gender is not limited; 2. Children with pneumonia before the age of 2 years; 3. Meet the diagnostic criteria for recurrent lower respiratory tract infections in children; 4. Meet the diagnostic criteria for severe pneumonia in children; 5. Voluntary test, informed consent of the child and legal guardian and signing of the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Exclude other diseases that cause cough and wheezing, such as primary ciliary dyskinesia and congenital bronchopulmonia Children with dysplasia, foreign body aspiration, tuberculosis, cystic fibrosis, etc., and children after cord blood stem cell transplantation; 2. Children with coagulation function and platelet count before bronchoalveolar lavage, and potential bleeding risk; 3. Combined with severe primary diseases such as cardiovascular and cerebrovascular, liver, kidney, hematopoietic system and endocrine system Serious illness that is considered inappropriate to participate in this study; 4. Indications for invasive mechanical ventilation and non-invasive ventilator application; 5. Participated in or is participating in other clinical trials in the past 1 month; 6. The investigator believes that it is not suitable to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
DNA methylation analysis of BALF samples;The DNA methylated CpG of COPD was established through GEO database, and the association between it and repeated lung infections in children was analyzed.;

Secondary

MeasureTime frame
Baseline clinical data of children;Follow-up of pulmonary function and pulmonary CT after discharge;

Countries

China

Contacts

Public ContactJianning Guo

China-Japan Friendship Hospital

Dr.jane93@outlook.com+86 153 1953 7768

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026